scholarly journals Small bowel enteroscopy in undiagnosed gastrointestinal blood loss.

Gut ◽  
1992 ◽  
Vol 33 (7) ◽  
pp. 887-889 ◽  
Author(s):  
A J Morris ◽  
L A Wasson ◽  
J F MacKenzie
Keyword(s):  
Small Bowel ◽  
Blood Loss ◽  
Gastrointestinal Blood Loss

Metastatic Small Bowel Melanoma Presenting as Gastrointestinal Blood Loss: A Case Report

2018 ◽  
Vol 113 (Supplement) ◽  
pp. S1423
Author(s):  
Vick S. DiCarlo ◽  
Rachel Mitchell ◽  
Kondal Rao Kyanam Kabir Baig ◽  
Ali M. Ahmed ◽  
Shajan Peter
Keyword(s):  
Case Report ◽  
Small Bowel ◽  
Blood Loss ◽  
Gastrointestinal Blood Loss

Controlled-release dosage forms and gastrointestinal blood loss: four clinical studies

1993 ◽  
Vol 91 (1) ◽  
pp. 75-84 ◽  
Author(s):  
F. Gilbert McMahon ◽  
Ramon Vargas ◽  
Philip Leese ◽  
Brian Crawford ◽  
Ann Konecny ◽  
...  
Keyword(s):  
Controlled Release ◽  
Blood Loss ◽  
Clinical Studies ◽  
Dosage Forms ◽  
Gastrointestinal Blood Loss

Quantitative measurement of gastrointestinal blood loss

1958 ◽  
Vol 25 (2) ◽  
pp. 169-181 ◽  
Author(s):  
Franklin G. Ebaugh ◽  
Ted Clemens ◽  
Gerald Rodnan ◽  
R.E. Peterson
Keyword(s):  
Blood Loss ◽  
Quantitative Measurement ◽  
Gastrointestinal Blood Loss

Nebulized Vasopressin for the Control of Hematemesis and Hemoptysis in a Child With Recurrent, Refractory Stage III Burkitt Lymphoma

2019 ◽  
Vol 35 (2) ◽  
pp. 71-74
Author(s):  
Jennifer D. Dulin ◽  
Patrick J. Coyne
Keyword(s):  
Side Effects ◽  
Small Bowel ◽  
Blood Loss ◽  
End Of Life ◽  
Normal Saline ◽  
Burkitt Lymphoma ◽  
Palliative Chemotherapy ◽  
Case Description ◽  
Goals Of Care ◽  
Intravenous Access

Background: Bleeding occurs with some regularity at the end of life. Patients often endure fatigue, weakness, pain, dyspnea and anxiety. These symptoms are magnified in visually apparent bleeds. Management can be particularly challenging as we attempt to balance therapies with goals of care. Children are at risk for such complications and symptoms; providers must ensure comfort for both the patient and family. Case Description: A 7-year-old male with recurrent, refractory Burkitt lymphoma was frequently hospitalized for palliative chemotherapy and disease complications. On his final admission, he experienced gross hemoptysis and hematemesis: he was short of breath, fatigued and anxious due to his blood loss. His and his family’s angst were heightened by “seeing” his bleed. Potential, especially invasive, treatments were limited by our goals to promote comfort, limit interventions, maintain alertness, poor intravenous access and a small bowel obstruction. Nebulized vasopressin, 10 units in 4ml of normal saline given over 10 minutes provided JC with needed relief. His bleeding remitted and he tolerated its administration. Conclusion: There are many treatments for hemorrhage; however, given the challenges of goals of care, administration, side-effects and tolerability, further investigation into nebulized vasopressin as a potential therapy for hemoptysis and hematemesis at the end-of-life is warranted.

Haemoglobin in gut lavage fluid as a measure of gastrointestinal blood loss

The Lancet ◽  
1992 ◽  
Vol 340 (8832) ◽  
pp. 1381-1382 ◽  
Author(s):  
W.G. Brydon ◽  
A. Ferguson
Keyword(s):  
Blood Loss ◽  
Lavage Fluid ◽  
Gastrointestinal Blood Loss ◽  
Gut Lavage

scholarly journals Acceptability of opportunistic screening for occult gastrointestinal blood loss.

BMJ ◽  
1992 ◽  
Vol 304 (6825) ◽  
pp. 483-486 ◽  
Author(s):  
F. D. Hobbs ◽  
R. C. Cherry ◽  
J. W. Fielding ◽  
L. Pike ◽  
R. Holder
Keyword(s):  
Blood Loss ◽  
Opportunistic Screening ◽  
Gastrointestinal Blood Loss
Sign in / Sign up

Export Citation Format

Share Document